Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Lung
Literature
1.
Hagmeyer L, Herkenrath S, Anduleit N, Treml M, Randerath W (2019) Cardiopulmonary exercise testing allows discrimination between idiopathic non-specific interstitial pneumonia and idiopathic pulmonary fibrosis in mild to moderate stages of the disease. Lung 197(6):721–726CrossRef
2.
American Thoracic Society; American College of Chest Physicians (2003) ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 167(2):211–277CrossRef
3.
George PM, Mitchell JA (2019) Defining a pathological role for the vasculature in the development of fibrosis and pulmonary hypertension in interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 317(4):L431–L433CrossRef
4.
Rose L, Prins KW, Archer SL, Pritzker M, Weir EK, Misialek JR, Thenappan T (2019) Survival in pulmonary hypertension due to chronic lung disease: influence of low diffusion capacity of the lungs for carbon monoxide. J Heart Lung Transpl. 38(2):145–155CrossRef
5.
Boutou AK, Pitsiou GG, Argyropoulou P (2014) Non-invasive markers of pulmonary hypertension in interstitial lung disease: is cardiopulmonary exercise testing the Holy Grail? Respirology 19(5):621–622CrossRef
Metadata
Title
Discriminating Between Non-Specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis at Early Stages: When CPET is Enough?
Author
Afroditi K. Boutou
Publication date
01-02-2020
Publisher
Springer US
Published in
Lung / Issue 1/2020
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-019-00316-2

Other articles of this Issue 1/2020

Lung 1/2020 Go to the issue

INTERVENTIONAL BRONCHOSCOPY

Screening for Bronchoscopic Lung Volume Reduction: Reasons for Not Receiving Interventional Treatment

LUNG CANCER

Lung Cancer in the Young

SLEEP

Positive Airway Pressure Adherence in Patients with Obstructive Sleep Apnea with Schizophrenia

STATE OF THE ART REVIEW

Current Status and Future Directions of Chronic Cough in China

PULMONARY HYPERTENSION

The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension

PLEURAL DISEASE

Increased E/A Ratio is a Risk Factor for the Formation of Pleural Effusion in Heart Failure

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits